Genome-Wide Analysis Reveals the Unique Stem Cell Identity of Human Amniocytes

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Maguire, Colin T ^a   Demarest, Bradley L ^a   Hill, Jonathon T ^a   Palmer, James D ^a   Brothman, Arthur R ^a,b,c   Yost, H Joseph ^a   Condic, Maureen L ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ANTIGEN; MEMBRANE ANTIGEN; STAGE SPECIFIC EMBRYO ANTIGEN 1; STAGE SPECIFIC EMBRYO ANTIGEN 3; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRA 1-60 ANTIGEN; TRA 1-81 ANTIGEN; TRANSCRIPTOME; UNCLASSIFIED DRUG;

AMNION CELL; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL HETEROGENEITY; CELL INTERACTION; CELL ISOLATION; CELL LINEAGE; CELL RENEWAL; CELL SURFACE; CONTROLLED STUDY; EMBRYO; FEMALE; FIBROBLAST; GENE CLUSTER; GENE EXPRESSION; GENETIC ASSOCIATION; GENOME ANALYSIS; GESTATIONAL AGE; HUMAN; HUMAN CELL; MALE; MOLECULAR CLONING; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84872258810     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053372     Document Type: Article

References (73)

1. De Santis M, De Luca C, Mappa I, Cesari E, Quattrocchi T, et al. (2011) In-utero stem cell transplantation: clinical use and therapeutic potential. Minerva Ginecol 63: 387-98.
2. Fauza D, (2004) Amniotic fluid and placental stem cells. Best Practice & Research Clinical Obstetrics & Gynaecology 18: 877-91.
3. Shaw SW, David AL, De Coppi P, (2011) Clinical applications of prenatal and postnatal therapy using stem cells retrieved from amniotic fluid. Curr Opin Obstet Gynecol 23: 109-16.
4. Kunisaki SM, (2012) Congenital anomalies: Treatment options based on amniotic fluid-derived stem cells. Organogenesis 1;8(3).
5. Antonucci I, Pantalone A, Tete S, Salini V, Borlongan CV, et al. (2012) Amniotic fluid stem cells: a promising therapeutic resource for cell-based regenerative therapy. Curr Pharm Des 18: 1846-63.
6. Walther G, Gekas J, Bertrand OF, (2009) Amniotic stem cells for cellular cardiomyoplasty: promises and premises. Catheter Cardiovasc Interv 73: 917-24.
7. Warburton D, Perin L, Defilippo R, Bellusci S, Shi W, et al. (2008) Stem/progenitor cells in lung development, injury repair, and regeneration. Proc Am Thorac Soc 5: 703-6.
8. Perin L, Giuliani S, Sedrakyan S, S DAS, De Filippo RE, (2008) Stem cell and regenerative science applications in the development of bioengineering of renal tissue. Pediatr Res 63: 467-71.
9. Mimeault M, Hauke R, Batra SK, (2007) Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Ther 82: 252-64.
10. Pozzobon M, Ghionzoli M, Coppi P, (2009) ES, iPS, MSC, and AFS cells. Stem cells exploitation for Pediatric Surgery: current research and perspective. Pediatric Surgery International 26: 3-10.
11. Prusa AR, Marton E, Rosner M, Bernaschek G, Hengstschlager M, (2003) Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? Human reproduction 18: 1489-93.
12. Tsai MS, Hwang SM, Tsai YL, Cheng FC, Lee JL, et al. (2006) Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biology of Reproduction 74: 545-51.
13. Jezierski A, Gruslin A, Tremblay R, Ly D, Smith C, et al. (2010) Probing stemness and neural commitment in human amniotic fluid cells. Stem Cell Rev 6: 199-214.
14. Woodbury D, Kramer BC, Reynolds K, Marcus AJ, Coyne TM, et al. (2006) Long-term cryopreserved amniocytes retain proliferative capacity and differentiate to ectodermal and mesodermal derivatives in vitro. Molecular Reproduction and Development 73: 1463-72.
15. Roubelakis MG, Pappa KI, Bitsika V, Zagoura D, Vlahou A, et al. (2007) Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Stem Cells Dev 16: 931-52.
16. Grisafi D, Piccoli M, Pozzobon M, Ditadi A, Zaramella P, et al. (2008) High transduction efficiency of human amniotic fluid stem cells mediated by adenovirus vectors. Stem Cells Dev 17: 953-62.
17. De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, et al. (2007) Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25: 100-6.
18. Moschidou D, Mukherjee S, Blundell MP, Drews K, Jones GN, et al. (2012) Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-free Approach. Mol Ther 20 (10):: 1953-67.
19. Li C, Zhou J, Shi G, Ma Y, Yang Y, et al. (2009) Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells. Hum Mol Genet 18: 4340-9.
20. Anchan RM, Quaas P, Gerami-Naini B, Bartake H, Griffin A, et al. (2010) Amniocytes can serve a dual function as a source of iPS cells and feeder layers. Human Molecular Genetics 20: 962-74.
21. Galende E, Karakikes I, Edelmann L, Desnick RJ, Kerenyi T, et al. (2009) Amniotic Fluid Cells Are More Efficiently Reprogrammed to Pluripotency Than Adult Cells. Cloning Stem Cells 12 (2):: 117-25.
22. Ge X, Wang IN, Toma I, Sebastiano V, Liu J, et al. (2012) Human amniotic mesenchymal stem cell-derived induced pluripotent stem cells may generate a universal source of cardiac cells. Stem cells and development 21 (15):: 2798-808.
23. Wolfrum K, Wang Y, Prigione A, Sperling K, Lehrach H, et al. (2010) The LARGE principle of cellular reprogramming: lost, acquired and retained gene expression in foreskin and amniotic fluid-derived human iPS cells. PLoS One 5: e13703.
24. Liu T, Zou G, Gao Y, Zhao X, Wang H, et al. (2012) High Efficiency of Reprogramming CD34(+) Cells Derived from Human Amniotic Fluid into Induced Pluripotent Stem Cells with Oct4. Stem cells and development 21 (12):: 2322-32.
25. Easley CAt, Miki T, Castro CA, Ozolek JA, Minervini CF, et al. (2012) Human Amniotic Epithelial Cells are Reprogrammed More Efficiently by Induced Pluripotency than Adult Fibroblasts. Cellular reprogramming 14: 193-203.
26. Prusa A-R, Marton E, Rosner M, Bettelheim D, Lubec G, et al. (2004) Neurogenic cells in human amniotic fluid. American Journal of Obstetrics and Gynecology 191: 309-14.
27. Bossolasco P, Montemurro T, Cova L, Zangrossi S, Calzarossa C, et al. (2006) Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential. Cell Res 16: 329-36.
28. Kolambkar YM, Peister A, Soker S, Atala A, Guldberg RE, (2007) Chondrogenic differentiation of amniotic fluid-derived stem cells. Journal of Molecular Histology 38: 405-13.
29. Perin L, Giuliani S, Jin D, Sedrakyan S, Carraro G, et al. (2007) Renal differentiation of amniotic fluid stem cells. Cell Prolif 40: 936-48.
30. Ditadi A, de Coppi P, Picone O, Gautreau L, Smati R, et al. (2009) Human and murine amniotic fluid c-Kit+Lin- cells display hematopoietic activity. Blood 113: 3953-60.
31. Decembrini S, Cananzi M, Gualdoni S, Battersby A, Allen N, et al. (2011) Comparative analysis of the retinal potential of embryonic stem cells and amniotic fluid-derived stem cells. Stem cells and development 20: 851-63.
32. Bottai D, Cigognini D, Nicora E, Moro M, Grimoldi MG, et al. (2012) Third trimester amniotic fluid cells with the capacity to develop neural phenotypes and with heterogeneity among sub-populations. Restor Neurol Neurosci 30: 55-68.
33. Ginsberg M, James D, Ding BS, Nolan D, Geng F, et al. (2012) Efficient Direct Reprogramming of Mature Amniotic Cells into Endothelial Cells by ETS Factors and TGFbeta Suppression. Cell 151 (3):: 559-75.
34. Parolini O, Soncini M, Evangelista M, Schmidt D, (2009) Amniotic membrane and amniotic fluid-derived cells: potential tools for regenerative medicine? Regen Med 4: 275-91.
35. Ang YS, Tsai SY, Lee DF, Monk J, Su J, et al. (2011) Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network. Cell 145: 183-97.
36. Ramirez JM, Gerbal-Chaloin S, Milhavet O, Qiang B, Becker F, et al. (2011) Brief report: benchmarking human pluripotent stem cell markers during differentiation into the three germ layers unveils a striking heterogeneity: all markers are not equal. Stem Cells 29: 1469-74.
37. Williams SA, Stanley P, (2009) Complex N-glycans or core 1-derived O-glycans are not required for the expression of stage-specific antigens SSEA-1, SSEA-3, SSEA-4, or Le(Y) in the preimplantation mouse embryo. Glycoconj J 26: 335-47.
38. Gooi HC, Feizi T, Kapadia A, Knowles BB, Solter D, et al. (1981) Stage-specific embryonic antigen involves alpha 1 goes to 3 fucosylated type 2 blood group chains. Nature 292: 156-8.
39. Underwood MA, Gilbert WM, Sherman MP, (2005) Amniotic Fluid: Not Just Fetal Urine Anymore. Journal of Perinatology 25: 341-48.
40. Cui X, Churchill GA, (2003) Statistical tests for differential expression in cDNA microarray experiments. Genome Biol 4: 210.
41. Phanstiel DH, Brumbaugh J, Wenger CD, Tian S, Probasco MD, et al. (2011) Proteomic and phosphoproteomic comparison of human ES and iPS cells. Nat Meth 8: 821-27.
42. Phanstiel DH, Brumbaugh J, Wenger CD, Tian S, Probasco MD, et al. (2011) Proteomic and phosphoproteomic comparison of human ES and iPS cells. Nature Methods 8: 821-7.
43. Young Richard A, (2011) Control of the Embryonic Stem Cell State. Cell 144: 940-54.
44. Sun C, Nakatake Y, Akagi T, Ura H, Matsuda T, et al. (2009) Dax1 binds to Oct3/4 and inhibits its transcriptional activity in embryonic stem cells. Molecular and Cellular Biology 29: 4574-83.
45. Plouzek CA, Leslie KK, Stephens JK, Chou JY, (1993) Differential gene expression in the amnion, chorion, and trophoblast of the human placenta. Placenta 14: 277-85.
46. Amps K, Andrews PW, Anyfantis G, Armstrong L, Avery S, et al. (2011) Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nature Biotechnology 29: 1132-44.
47. Aula P, von Koskull H, Teramo K, Karjalainen O, Virtanen I, et al. (1980) Glial origin of rapidly adhering amniotic fluid cells. Br Med J 281: 1456-7.
48. von Koskull H, Virtanen I, Lehto VP, Vartio T, Dahl D, et al. (1981) Glial and neuronal cells in amniotic fluid of anencephalic pregnancies. Prenatal diagnosis 1: 259-67.
49. Chen WW, (1982) Studies on the origin of human amniotic fluid cells by immunofluorescent staining of keratin filaments. J Med Genet 19: 433-6.
50. Heikinheimo M, Wahlstrom T, Aula P, Virtanen I, Seppala M, (1980) Pregnancy-specific beta-1-glycoprotein (SP1) in cultured amniotic fluid cells. J Clin Endocrinol Metab 51: 1432-6.
51. Gosden CM, (1983) Amniotic fluid cell types and culture. Br Med Bull 39: 348-54.
52. Hoehn H, Salk D, (1982) Morphological and biochemical heterogeneity of amniotic fluid cells in culture. Methods in cell biology 26: 11-34.
53. Dobreva MP, Pereira PNG, Deprest J, Zwijsen A, (2010) On the origin of amniotic stem cells: of mice and men. The International Journal of Developmental Biology 54: 761-77.
54. Kanai-Azuma M, Kanai Y, Gad JM, Tajima Y, Taya C, et al. (2002) Depletion of definitive gut endoderm in Sox17-null mutant mice. Development 129: 2367-79.
55. Niakan KK, Ji H, Maehr R, Vokes SA, Rodolfa KT, et al. (2010) Sox17 promotes differentiation in mouse embryonic stem cells by directly regulating extraembryonic gene expression and indirectly antagonizing self-renewal. Genes & Development 24: 312-26.
56. Frankenberg S, Gerbe F, Bessonnard S, Belville C, Pouchin P, et al. (2011) Primitive endoderm differentiates via a three-step mechanism involving Nanog and RTK signaling. Developmental Cell 21: 1005-13.
57. Nichols J, Smith A, (2010) The origin and identity of embryonic stem cells. Development 138: 3-8.
58. Nichols J, Smith A, (2009) Naive and Primed Pluripotent States. Cell Stem Cell 4: 487-92.
59. Bilic J, Belmonte JCI, (2012) Concise Review: Induced Pluripotent Stem Cells Versus Embryonic Stem Cells: Close Enough or Yet Too Far Apart? Stem Cells 30: 33-41.
60. Stewart MH, Bosse M, Chadwick K, Menendez P, Bendall SC, et al. (2006) Clonal isolation of hESCs reveals heterogeneity within the pluripotent stem cell compartment. Nature Methods 3: 807-15.
61. Narsinh KH, Sun N, Sanchez-Freire V, Lee AS, Almeida P, et al. (2011) Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells. The Journal of clinical investigation 121: 1217-21.
62. Chambers I, Silva J, Colby D, Nichols J, Nijmeijer B, et al. (2007) Nanog safeguards pluripotency and mediates germline development. Nature 450: 1230-4.
63. Toyooka Y, Shimosato D, Murakami K, Takahashi K, Niwa H, (2008) Identification and characterization of subpopulations in undifferentiated ES cell culture. Development 135: 909-18.
64. Graf T, Stadtfeld M, (2008) Heterogeneity of embryonic and adult stem cells. Cell Stem Cell 3: 480-3.
65. Hayashi K, Lopes SM, Tang F, Surani MA, (2008) Dynamic equilibrium and heterogeneity of mouse pluripotent stem cells with distinct functional and epigenetic states. Cell Stem Cell 3: 391-401.
66. Hanna J, Cheng AW, Saha K, Kim J, Lengner CJ, et al. (2010) Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. PNAS 107: 9222-7.
67. Marks H, Kalkan T, Menafra R, Denissov S, Jones K, et al. (2012) The transcriptional and epigenomic foundations of ground state pluripotency. Cell 149: 590-604.
68. Eckmann-Scholz C, Bens S, Kolarova J, Schneppenheim S, Caliebe A, et al. (2012) DNA-Methylation Profiling of Fetal Tissues Reveals Marked Epigenetic Differences between Chorionic and Amniotic Samples. PLoS One 7: e39014.
69. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, et al. (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55: 611-22.
70. Nix DA, Courdy SJ, Boucher KM, (2008) Empirical methods for controlling false positives and estimating confidence in ChIP-Seq peaks. BMC Bioinformatics 9: 523.
71. R Development Core Team (2012) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.r-project.org/.
72. Anders S, Huber W, (2010) Differential expression analysis for sequence count data. Genome Biol 11: R106.
73. SuzukiR and Shimodaira H (2012) pvclust: Hierarchical Clustering with P-Values via Multiscale Bootstrap Resampling. R package version 1.2-2. URL http://cran.r-project.org/web/packages/pvclust/index.html.